Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Medtronic
Johnson and Johnson
Federal Trade Commission
Healthtrust
Daiichi Sankyo

Generated: August 24, 2019

DrugPatentWatch Database Preview

Details for Patent: 8,889,190

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Which drugs does patent 8,889,190 protect, and when does it expire?

Patent 8,889,190 protects QUDEXY XR and is included in one NDA.

This patent has eight patent family members in six countries.

Summary for Patent: 8,889,190
Title:Extended-release topiramate capsules
Abstract: An extended-release topiramate capsule that includes a capsule shell containing a single population of coated particles; wherein each coated particle includes a core and a coating thereon; wherein each particle core includes a homogeneous mixture comprising topiramate throughout its core; and wherein the coating includes one or more release controlling agent(s).
Inventor(s): Betterman; Sarah Michelle (Champlin, MN), Tantry; Jaidev Srinivas (Maple Grove, MN), Patrick; Laura Marie (Eden Prairie, MN)
Assignee: Upsher-Smith Laboratories, Inc. (Maple Grove, MN)
Application Number:14/157,646
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,889,190
Patent Claim Types:
see list of patent claims
Composition; Dosage form;

Drugs Protected by US Patent 8,889,190

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Upsher Smith Labs QUDEXY XR topiramate CAPSULE, EXTENDED RELEASE;ORAL 205122-001 Mar 11, 2014 BC RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Upsher Smith Labs QUDEXY XR topiramate CAPSULE, EXTENDED RELEASE;ORAL 205122-002 Mar 11, 2014 BC RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Upsher Smith Labs QUDEXY XR topiramate CAPSULE, EXTENDED RELEASE;ORAL 205122-003 Mar 11, 2014 BC RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Upsher Smith Labs QUDEXY XR topiramate CAPSULE, EXTENDED RELEASE;ORAL 205122-004 Mar 11, 2014 RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Upsher Smith Labs QUDEXY XR topiramate CAPSULE, EXTENDED RELEASE;ORAL 205122-005 Mar 11, 2014 BC RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Teva
Harvard Business School
Covington
Colorcon
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.